CHICAGO — One person’s used pacemaker is another person’s treasure. A program to refurbish used pacemakers could expand access to the lifesaving devices. In a clinical trial of nearly 300 people, ...
The U.S. Food and Drug Administration has given Medtronic (NYSE:MDT) the go-ahead on a clinical trial to test its next generation of MRI pacemaker technology, the Minnesota company announced Monday.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback